STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to assess the efficacy of a weekly treatment regimen of STA-4783 and
paclitaxel in comparison to paclitaxel alone on tumor response in metastatic melanoma
patients.